Ischemic postconditioning can reduce myocardial injury following myocardial infarction. A potential pharmacological agent is the anesthetic Sevoflurane. The investigators' hypothesis is that sevoflurane during primary percutaneous coronary intervention (PCI) will reduce infarct size.
Patients with first STEMI that will be treated by primary PCI, will be randomized to sedation with Sevoflurane during the procedure or to usual care.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
50
Oxygen with end-tidal MAC of Sevoflurane 0.5 during PCI.
Control will receive oxygen only.
London Health Sceinces Centre
London, Ontario, Canada
Infarct size by area under the curve of cardiac markers.
Time frame: 3 days
Left ventricular function.
Time frame: Six month
ST segment elevation resolution
Time frame: 90 minutes
TIMI flow
Time frame: 60 minutes
Renal function
Time frame: 48 hours
CRP
Time frame: 24 hours
Patient satisfaction
Time frame: 1 hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.